Credit Suisse’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $297K | Sell |
|
|||||
|
2019
Q4 | $848K | Buy |
|
|||||
|
2019
Q3 | $279K | Buy |
|
|||||
|
2019
Q2 | $333K | Sell |
|
|||||
|
2019
Q1 | $410K | Buy |
|
|||||
|
2018
Q4 | $221K | Sell |
|
|||||
|
2018
Q3 | $492K | Buy |
|
|||||
|
2018
Q2 | $517K | Sell |
|
|||||
|
2018
Q1 | $523K | Buy |
|
|||||
|
2017
Q4 | $401K | Sell |
|
|||||
|
2017
Q3 | $699K | Sell |
|
|||||
|
2017
Q2 | $793K | Sell |
|
|||||
|
2017
Q1 | $1.45M | Buy |
|
|||||
|
2016
Q4 | $697K | Sell |
|
|||||
|
2016
Q3 | $612K | Buy |
|
|||||
|
2016
Q2 | $351K | Sell |
|
|||||
|
2016
Q1 | $404K | Buy |
|
|||||
|
2015
Q4 | $362K | Buy |
|
|||||
|
2015
Q3 | $306K | Sell |
|
|||||
|
2015
Q2 | $2.19M | Buy |
|
|||||
|
2015
Q1 | $734K | Buy |
|
|||||
|
2014
Q4 | $833K | Buy |
|
|||||
|
2014
Q3 | $186K | Sell |
|
|||||
|
2014
Q2 | $199K | Sell |
|
|||||
|
2014
Q1 | $607K | Sell |
|
|||||
|
2013
Q4 | $1.39M | Buy |
|
|||||
|
2013
Q3 | $1.15M | Sell |
|
|||||
|
2013
Q2 | $1.13M | Buy |
|